178 related articles for article (PubMed ID: 17696227)
1. Bravo (wireless) ambulatory esophageal pH monitoring: how do day 1 and day 2 results compare?
Bechtold ML; Holly JS; Thaler K; Marshall JB
World J Gastroenterol; 2007 Aug; 13(30):4091-5. PubMed ID: 17696227
[TBL] [Abstract][Full Text] [Related]
2. 24 Versus 48-hour bravo pH monitoring.
Chander B; Hanley-Williams N; Deng Y; Sheth A
J Clin Gastroenterol; 2012 Mar; 46(3):197-200. PubMed ID: 21959323
[TBL] [Abstract][Full Text] [Related]
3. Continuous 48-Hour Wireless Esophageal pH Monitoring in Children: Comparison Between Days 1 and 2.
Ravi A; Gunasekaran T; Berman J
J Pediatr Gastroenterol Nutr; 2016 Jan; 62(1):87-9. PubMed ID: 26196198
[TBL] [Abstract][Full Text] [Related]
4. Esophagogastroduodenoscopy with conscious sedation does not interfere with catheter-based 24-h pH monitoring.
Tsou YK; Lien JM; Chen CK; Lin CH; Chen HY; Lee MS
World J Gastroenterol; 2013 Mar; 19(11):1805-10. PubMed ID: 23555169
[TBL] [Abstract][Full Text] [Related]
5. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
Schey R; Alla SP; Midani D; Parkman HP
Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
[TBL] [Abstract][Full Text] [Related]
6. Day-to-day variability in acid reflux patterns using the BRAVO pH monitoring system.
Ahlawat SK; Novak DJ; Williams DC; Maher KA; Barton F; Benjamin SB
J Clin Gastroenterol; 2006 Jan; 40(1):20-4. PubMed ID: 16340628
[TBL] [Abstract][Full Text] [Related]
7. Does deep sedation impact the results of 48 hours catheterless pH testing?
Korrapati V; Babich JP; Balani A; Grendell JH; Kongara KR
World J Gastroenterol; 2011 Mar; 17(10):1304-7. PubMed ID: 21455329
[TBL] [Abstract][Full Text] [Related]
8. Impact of prolonged 48-h wireless capsule esophageal pH monitoring on diagnosis of gastroesophageal reflux disease and evaluation of the relationship between symptoms and reflux episodes.
Domingues GR; Moraes-Filho JP; Domingues AG
Arq Gastroenterol; 2011; 48(1):24-9. PubMed ID: 21537538
[TBL] [Abstract][Full Text] [Related]
9. [Catheter-free pH-metry using the Bravo capsule versus standard pH-metry in patients with non-erosive reflux disease (NERD)].
Mönkemüller K; Neumann H; Fry LC; Kolfenbach S; Malfertheiner P
Z Gastroenterol; 2009 Apr; 47(4):351-6. PubMed ID: 19358061
[TBL] [Abstract][Full Text] [Related]
10. To Bravo or not? A comparison of wireless esophageal pH monitoring and conventional pH catheter to evaluate non-erosive gastroesophageal reflux disease in a multiracial Asian cohort.
Ang D; Teo EK; Ang TL; Ong J; Poh CH; Tan J; Fock KM
J Dig Dis; 2010 Feb; 11(1):19-27. PubMed ID: 20132427
[TBL] [Abstract][Full Text] [Related]
11. Oesophageal pH monitoring using the Bravo catheter-free radio capsule.
Gillies RS; Stratford JM; Booth MI; Dehn TC
Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):57-63. PubMed ID: 17206078
[TBL] [Abstract][Full Text] [Related]
12. Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure.
de Bortoli N; Martinucci I; Savarino E; Franchi R; Bertani L; Russo S; Ceccarelli L; Costa F; Bellini M; Blandizzi C; Savarino V; Marchi S
Dis Esophagus; 2016 Jan; 29(1):3-9. PubMed ID: 25212408
[TBL] [Abstract][Full Text] [Related]
13. Effect of anesthesia on gastroesophageal reflux in children: a study using BRAVO wireless pH study measurements.
Rodriguez L; Morley-Fletcher A; Souza A; Rosengaus L; Nurko S
Neurogastroenterol Motil; 2015 Nov; 27(11):1553-8. PubMed ID: 26264213
[TBL] [Abstract][Full Text] [Related]
14. 48-Hour pH monitoring increases the risk of false positive studies when the capsule is prematurely passed.
Iqbal A; Lee YK; Vitamvas M; Oleynikov D
J Gastrointest Surg; 2007 May; 11(5):638-41. PubMed ID: 17468923
[TBL] [Abstract][Full Text] [Related]
15. Wireless ambulatory pH studies: manometric or endoscopic guidance?
Nusrat S; Roy PM; Bielefeldt K
Dis Esophagus; 2012 Jan; 25(1):26-32. PubMed ID: 21676068
[TBL] [Abstract][Full Text] [Related]
16. The impact of prolonged pH measurements on the diagnosis of gastroesophageal reflux disease: 4-day wireless pH studies.
Scarpulla G; Camilleri S; Galante P; Manganaro M; Fox M
Am J Gastroenterol; 2007 Dec; 102(12):2642-7. PubMed ID: 17850412
[TBL] [Abstract][Full Text] [Related]
17. 24-h multichannel intraluminal impedance-pH monitoring may be an inadequate test for detecting gastroesophageal reflux in patients with mixed typical and atypical symptoms.
Han MS; Lada MJ; Nieman DR; Tschoner A; Peyre CG; Jones CE; Watson TJ; Peters JH
Surg Endosc; 2015 Jul; 29(7):1700-8. PubMed ID: 25398192
[TBL] [Abstract][Full Text] [Related]
18. Day-to-day discrepancy in Bravo pH monitoring is related to the degree of deterioration of the lower esophageal sphincter and severity of reflux disease.
Ayazi S; Hagen JA; Zehetner J; Banki F; Augustin F; Ayazi A; DeMeester SR; Oh DS; Sohn HJ; Lipham JC; DeMeester TR
Surg Endosc; 2011 Jul; 25(7):2219-23. PubMed ID: 21359906
[TBL] [Abstract][Full Text] [Related]
19. Esophageal pH monitoring with the BRAVO capsule: experience in a single tertiary medical center.
Cabrera J; Davis M; Horn D; Pfefferkorn M; Croffie JM
J Pediatr Gastroenterol Nutr; 2011 Oct; 53(4):404-8. PubMed ID: 21519281
[TBL] [Abstract][Full Text] [Related]
20. Interference with daily activities and major adverse events during esophageal pH monitoring with bravo wireless capsule versus conventional intranasal catheter: a systematic review of randomized controlled trials.
Iluyomade A; Olowoyeye A; Fadahunsi O; Thomas L; Libend CN; Ragunathan K; Fenster J; Vignesh S
Dis Esophagus; 2017 Feb; 30(3):1-9. PubMed ID: 26952638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
